Open AccessPersonalized medicine in cardiovascular disease: review of literature
Author(s) -
Ali Sheikhy,
Aida Fallahzadeh,
Hamid Reza Aghaei Meybodi,
Mandana Hasanzad,
Masih Tajdini,
Kaveh Hosseini
Publication year - 2021
Publication title -
journal of diabetes and metabolic disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.619
H-Index - 33
ISSN - 2251-6581
DOI - 10.1007/s40200-021-00840-0
Subject(s) - personalized medicine , medicine , disease , coronary artery disease , clopidogrel , pharmacogenetics , precision medicine , pharmacogenomics , intensive care medicine , warfarin , atrial fibrillation , cardiology , bioinformatics , pharmacology , myocardial infarction , genotype , pathology , biochemistry , chemistry , gene , biology
Personalized medicine (PM) is the concept of managing patients based on their characteristics, including genotypes. In the field of cardiology, advantages of PM could be found in the diagnosis and treatment of several conditions such as arrhythmias and cardiomyopathies; moreover, it may be beneficial to prevent adverse drug reactions (ADR) and select the best medication. Genetic background can help us in selecting effective treatments, appropriate dose requirements, and preventive strategies in individuals with particular genotypes.